📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial. (2021)

First Author: Pratt AG

Attributed to: MICA: Targeting the RA synovial fibroblast via cyclin dependent kinase inhibition - a phase IIa study funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/ s2665-9913(21)00061-8

PubMed Identifier: 33928262

Publication URI: http://europepmc.org/abstract/MED/33928262

Type: Journal Article/Review

Volume: 3

Parent Publication: The Lancet. Rheumatology

Issue: 5

ISSN: 2665-9913